Data / Drug companies / Buspirone hydrochloride
Buspirone hydrochloride: 50 companies and 271 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Buspirone hydrochloride is listed in the FDA National Drug Code Directory by 50 companies, with 271 products in commercial distribution. 271 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, and the newest product started marketing on November 1, 2026.
The request: Get every company that lists buspirone hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 50
- Products
- 271
- Generic (ANDA) products
- 271 (100.0%)
- Application numbers
- 16
- Routes
- Oral
- Brand names
- busPIRone HCl, Bucapsol
- openFDA record search
- api.fda.gov
Companies that list buspirone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 25 | tablet | Generic drugs (ANDA) | June 17, 2024 |
| Aphena Pharma Solutions - Tennessee, LLC | 20 | tablet | Generic drugs (ANDA) | September 18, 2025 |
| A-S Medication Solutions | 19 | tablet | Generic drugs (ANDA) | September 26, 2025 |
| Epic Pharma, LLC | 12 | tablet; capsule | Generic drugs (ANDA) | March 13, 2025 |
| Remedyrepack Inc. | 12 | tablet | Generic drugs (ANDA) | March 19, 2026 |
| Bryant Ranch Prepack | 8 | tablet | Generic drugs (ANDA) | July 27, 2020 |
| Cardinal Health 107, LLC | 7 | tablet | Generic drugs (ANDA) | September 2, 2026 |
| Proficient Rx LP | 7 | tablet | Generic drugs (ANDA) | July 27, 2020 |
| Asclemed USA, Inc. | 6 | tablet | Generic drugs (ANDA) | October 17, 2023 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet | Generic drugs (ANDA) | October 17, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | July 27, 2020 |
| Unichem Pharmaceuticals (USA), Inc. | 6 | tablet | Generic drugs (ANDA) | October 17, 2023 |
| Accord Healthcare Inc. | 5 | tablet | Generic drugs (ANDA) | December 15, 2016 |
| Advagen Pharma Ltd | 5 | tablet | Generic drugs (ANDA) | March 16, 2021 |
| AiPing Pharmaceutical, Inc. | 5 | tablet | Generic drugs (ANDA) | September 26, 2025 |
| Apnar Pharma LP | 5 | tablet | Generic drugs (ANDA) | June 17, 2024 |
| Aurobindo Pharma Limited | 5 | tablet | Generic drugs (ANDA) | February 21, 2020 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | March 21, 2023 |
| Golden State Medical Supply, Inc. | 5 | tablet | Generic drugs (ANDA) | February 17, 2017 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet | Generic drugs (ANDA) | February 17, 2017 |
| Radha Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | September 18, 2025 |
| Rising Pharma Holdings, Inc. | 5 | tablet | Generic drugs (ANDA) | February 27, 2026 |
| Strides Pharma Inc. | 5 | tablet | Generic drugs (ANDA) | April 1, 2021 |
| Strides Pharma Science Limited | 5 | tablet | Generic drugs (ANDA) | February 17, 2017 |
| Zydus Lifesciences Limited | 5 | tablet | Generic drugs (ANDA) | March 21, 2023 |
| Zydus Pharmaceuticals USA Inc. | 5 | tablet | Generic drugs (ANDA) | March 21, 2023 |
| Advanced Rx of Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | March 20, 2025 |
| American Health Packaging | 4 | tablet | Generic drugs (ANDA) | November 1, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | June 29, 2012 |
| Mylan Institutional Inc. | 4 | tablet | Generic drugs (ANDA) | December 1, 2002 |
| Mylan Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | March 21, 2002 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | December 20, 2022 |
| Oxford Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | July 27, 2020 |
| Pangea Pharmaceuticals, LLC | 4 | capsule | Generic drugs (ANDA) | April 10, 2026 |
| Preferred Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | June 1, 2024 |
| Safecor Health, LLC | 4 | tablet | Generic drugs (ANDA) | February 4, 2026 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet | Generic drugs (ANDA) | March 26, 2004 |
| Major Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | May 3, 2014 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | July 3, 2018 |
| Unit Dose Solutions, Inc. | 3 | tablet | Generic drugs (ANDA) | June 15, 2026 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | June 10, 2026 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | April 12, 2021 |
| Ipg Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 29, 2026 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | March 1, 2002 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | October 21, 2020 |
| Boswell Pharmacy Services LLC D/B/A BPS Wholesale | 1 | tablet | Generic drugs (ANDA) | November 13, 2025 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | July 26, 2019 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | June 19, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | December 15, 2016 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | February 28, 2002 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 264 | 97.4% |
| Capsule | 7 | 2.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 271 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.